Long-Term Shareholders of Erasca, Inc. (ERAS) Are Encouraged to Contact Johnson Fistel Regarding Potential Claims
SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Erasca, Inc. (NASDAQ: ERAS) against certain of its officers and directors for alleged breaches of fiduciary duty.
What Should Erasca Shareholders Do?
If you have held Erasca shares continuously since prior to January 14, 2025, you may have standing to seek corporate governance reforms at Erasca, including improvements to internal controls, transparency, and executive oversight.
To learn more, visit: https://www.johnsonfistel.com/investigations/erasca/
You may also contact Johnson Fistel, PLLP at jimb@johnsonfistel.com or (619) 814-4471. There is no cost or obligation to you.
Complaint Allegations
A previously filed securities complaint alleges, on April 27, 2026, Erasca disclosed that it had received a letter from Revolution Medicines alleging that ERAS-0015 infringed a Revolution Medicines patent, was connected to alleged trade-secret misappropriation, and had been improperly compared with Revolution Medicines’ RMC-6236 in public disclosures. The complaint further alleges that Erasca later reported preliminary Phase 1 clinical data for ERAS-0015, disclosed that a patient who received ERAS-0015 had died, and acknowledged that comparisons between ERAS-0015 and other product candidates were based on cross-study analyses rather than head-to-head clinical trials and were inherently limited.
About Johnson Fistel, PLLP | Top Law Firm, Securities Fraud, Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. The firm also represents foreign investors who have purchased securities on U.S. exchanges.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contacts
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker | (619) 814-4471
jimb@johnsonfistel.com
https://www.johnsonfistel.com/
